$BDX

BECTON DICKINSON & CO

Becton Dickinson, commonly known as BD, is a global medical technology company headquartered in Franklin Lakes, New Jersey. It develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD’s worldwide operations include Medical, Life Sciences and Interventional, reorganized into five separately managed segments effective October 1, 2025: Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences. BD Medical offers products for medication delivery and management, pharmaceutical drug delivery systems and patient monitoring. BD Life Sciences supplies specimen collection and transport products, diagnostic instruments and reagents, and tools for cell research. BD Interventional provides vascular, urology, oncology and surgical products, including devices that are implanted or used once and discarded. BD markets and distributes products directly and through independent distribution channels, including distributors and sales representatives.

1
0
2
—
$4.3M
Polen Thomas E Jr
100%
See all $BDX insider activity →
Low

BD, Pharmatrade launch UAE’s first robot-automated pharmacy

BD (Becton, Dickinson and Company) and Pharmatrade launched the UAE's first robot-automated pharmacy system, BD Rowa, at Community Health Solutions Pharmacy. The system automates medication storage, retrieval, and inventory management, aiming to improve efficiency and patient care. BD and Pharmatrade highlight the role of technology in advancing the UAE's healthcare transformation.

New Australian Data Shed Even More Light on Tax Avoidance by Big Tech (and Others), Highlight Need for Better Disclosure in the U.S.

The Australian Taxation Office released country-by-country tax reports, revealing that Apple (25% of profits in Singapore) and Visa (62% of profits in Singapore) booked significant profits in low-tax jurisdictions. Becton Dickinson reported $266.2M pretax income in the Cayman Islands with no local employees. The data highlights discrepancies between U.S. and Australian disclosures, raising concerns about tax transparency.

BDX sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning BDX (BECTON DICKINSON & CO). Coverage has skewed bearish: 1 bullish, 0 neutral, and 2 bearish.

Recent BDX coverage spans financial news, insider activity and technology.

In the last 30 days, BDX insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($4.3M). The most active reporter was Polen Thomas E Jr, Chairman, CEO and President, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving BDX

AlphAI scores every news story that mentions BDX with an AI model for sentiment and relevance, and aggregates insider trades from BECTON DICKINSON & CO's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $BDX

Score

BD, Pharmatrade launch UAE’s first robot-automated pharmacy

BD (Becton, Dickinson and Company) and Pharmatrade launched the UAE's first robot-automated pharmacy system, BD Rowa, at Community Health Solutions Pharmacy. The system automates medication storage, retrieval, and inventory management, aiming to improve efficiency and patient care. BD and Pharmatrade highlight the role of technology in advancing the UAE's healthcare transformation.

New Australian Data Shed Even More Light on Tax Avoidance by Big Tech (and Others), Highlight Need for Better Disclosure in the U.S.

The Australian Taxation Office released country-by-country tax reports, revealing that Apple (25% of profits in Singapore) and Visa (62% of profits in Singapore) booked significant profits in low-tax jurisdictions. Becton Dickinson reported $266.2M pretax income in the Cayman Islands with no local employees. The data highlights discrepancies between U.S. and Australian disclosures, raising concerns about tax transparency.

Related tickers